A shadow market for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Experimental Treatment Gaining Traction Online
The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Followers are urged to contact these profiles privately for supplier links, while also receiving discount codes.
Active Trade on Social Networks
Separately, a flourishing trade exists on messaging services, where communities with thousands of participants share comparison photos, administration instructions and claims of next-day UK delivery. Vendors promote the drug there before directing buyers to other platforms for transactions.
Understanding The Experimental Drug
This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.
Medical Experts Voice Concerns
However, physicians and pharmacists have cautions that the distribution of what is still an unapproved drug in the United Kingdom is a cause for concern and could result in individuals administering substances of uncertain source.
Some experts said the popularity for the experimental drug could be connected to the increasing cost of licensed weight loss treatments such as Mounjaro.
Legal Status and Implementation
Selling the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unapproved medication that must not be promoted or distributed for human use under the British medical regulations.
Some influencers try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still breach medicines, advertising, and consumer regulations, risking fines, prosecution or prison.
Service Reaction and Content Elimination
According to TikTok, the platform has removed problematic material and prohibited related hashtags and query recommendations. The company said it was committed to keeping the platform safe and investing in enhancing compliance measures.
Online Trading Activities
Research also discovered groups with up to 9,000 participants marketing retatrutide using Telegram's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” instantly displays channels with numerous of users, populated with images of weight loss, positive reviews and step-by-step guides for preparing or injecting at residence.
Within minutes of joining one community, a vendor posted contact information, where the majority of transactions take place. The seller provided an instruction manual and promised delivery within two days. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about weight, medical conditions or past usage.
Item Information and Pricing
Within these groups, posts display black plastic packages with Royal Mail labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at home with purified liquid, or pre-filled pens usually sold at 160 pounds for 20mg. When asked how much time a pen should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.
Service Moderation and Safety Actions
A representative for Telegram stated it actively monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are injecting materials they cannot confirm. Although the science behind retatrutide is sound, these digital versions may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to current cost increases for authorized weight-loss drugs such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake injections are extremely risky. You cannot know what’s inside or whether the conditions they were made in was sterile,” she said.
Her team has previously encountered patients injured by personal administration from unverified sources. “We understand the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Statement
A spokesperson from Eli Lilly said the substance was in third stage clinical trials and had not been evaluated or authorized by any government authority globally. “Consequently at this point no one can sell [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a company experimental product not yet approved … may subject patients to potentially serious medical dangers”.
